5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.30▼ | 1.34▼ | 1.34▼ | 1.43▼ | 1.56▼ |
MA10 | 1.33▼ | 1.36▼ | 1.37▼ | 1.53▼ | 1.38▼ |
MA20 | 1.36▼ | 1.40▼ | 1.42▼ | 1.63▼ | 1.07▲ |
MA50 | 1.42▼ | 1.46▼ | 1.48▼ | 1.31▼ | 0.92▲ |
MA100 | 1.46▼ | 1.53▼ | 1.63▼ | 1.04▲ | 1.07▲ |
MA200 | 1.53▼ | 1.63▼ | 1.61▼ | 0.96▲ | 2.00▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.008▼ | -0.011▼ | -0.068▼ | 0.052▲ |
RSI | 32.540▼ | 32.918▼ | 33.225▼ | 42.634▼ | 54.346▲ |
STOCH | 3.519▼ | 17.886▼ | 17.939▼ | 33.438 | 42.071 |
WILL %R | -90.476▼ | -93.548▼ | -95.238▼ | -94.366▼ | -70.004 |
CCI | -93.605 | -163.775▼ | -147.993▼ | -122.613▼ | 20.753 |
Wednesday, March 03, 2021 07:36 AM
Analysts expect AzurRx BioPharma, Inc. (NASDAQ:AZRX) to announce earnings per share (EPS) of ($0.13) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for AzurRx ...
|
Tuesday, March 02, 2021 10:31 AM
March 02, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for ...
|
Tuesday, March 02, 2021 04:24 AM
AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, today ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/03/21 | 1.40 | 1.45 | 1.29 | 1.30 | 2,297,150 |
02/03/21 | 1.50 | 1.50 | 1.36 | 1.39 | 1,418,748 |
01/03/21 | 1.50 | 1.52 | 1.4501 | 1.50 | 621,979 |
26/02/21 | 1.50 | 1.52 | 1.35 | 1.44 | 1,354,953 |
25/02/21 | 1.66 | 1.66 | 1.48 | 1.51 | 2,062,958 |
24/02/21 | 1.47 | 1.7296 | 1.451 | 1.69 | 2,423,676 |
23/02/21 | 1.43 | 1.48 | 1.26 | 1.48 | 2,721,904 |
22/02/21 | 1.67 | 1.7003 | 1.55 | 1.59 | 2,036,151 |
19/02/21 | 1.68 | 1.7274 | 1.65 | 1.71 | 1,426,929 |
18/02/21 | 1.70 | 1.735 | 1.62 | 1.66 | 1,990,326 |
|
|
||||
|
|
||||
|
|